Drugs / Cannabinoid Oil Oral Preparation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04569760 | Apr 2021 → Apr 2023 | agoraphobia, generalized anxiety disorder, panic disorder, social phobia | McMaster University | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cannabinoid Oil Oral Preparation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04569760 ↗ |
| Route | Oral | “Oral cannabinoid oil preparation dosed in 1ml increments” NCT04569760 ↗ |